Rigel Pharmaceuticals (RIGL) Restructuring Costs (2013 - 2016)
Rigel Pharmaceuticals (RIGL) recorded quarterly Restructuring Costs of $5.8 million in Q3 2016, up 2314.23% quarter-over-quarter from $239000.0 in Q3 2013.
Rigel Pharmaceuticals (RIGL) Restructuring Costs (2013 - 2016) Analysis & Trends
Rigel Pharmaceuticals' Restructuring Costs history runs 2 years deep, the most recent figure standing at $5.8 million for Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Rigel Pharmaceuticals | 603.18 Mn | 456.49 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 5.77 Mn |
| Sep 30, 2013 | 239,000.00 |